<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01260389</url>
  </required_header>
  <id_info>
    <org_study_id>EC/2010/587</org_study_id>
    <nct_id>NCT01260389</nct_id>
  </id_info>
  <brief_title>Pharmaceutical Care for Chronic Obstructive Pulmonary Disease (COPD) Study.</brief_title>
  <acronym>PHARMACOP</acronym>
  <official_title>Pharmaceutical Care for COPD Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Ghent</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study would like to test the hypothesis that a pharmaceutical care intervention would
      result in an improved drug adherence and inhalation technique in Chronic Obstructive
      Pulmonary Disease (COPD) patients over a 3 month-period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Effective pharmacologic management of Chronic Obstructive Pulmonary Disease (COPD) not only
      involves prescription of recommended medicines by the physician, but also implies correct use
      of the prescribed medication by the patient (ie, good drug adherence and correct inhalation
      technique). Community pharmacists could help to improve the latter aspect, by delivering
      pharmaceutical care. The present randomised controlled trial will study the hypothesis that a
      pharmaceutical care intervention would result in an improved drug adherence and inhalation
      technique in COPD patients over a 3 month-period.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>inhalation technique baseline</measure>
    <time_frame>baseline</time_frame>
    <description>Inhalation technique with Chronic Obstructive Pulmonary Disease (COPD) controller medication at baseline.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>inhalation technique 1 month</measure>
    <time_frame>after 1 month</time_frame>
    <description>Inhalation technique with Chronic Obstructive Pulmonary Disease (COPD) controller medication after 1 month.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>inhalation technique 3 months</measure>
    <time_frame>after 3 months</time_frame>
    <description>Inhalation technique with Chronic Obstructive Pulmonary Disease (COPD) controller medication after 3 months.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>drug adherence</measure>
    <time_frame>after 3 months</time_frame>
    <description>Adherence to Chronic Obstructive Pulmonary Disease (COPD) controller medication after 3 months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>health status</measure>
    <time_frame>baseline</time_frame>
    <description>Health status, measured by:
the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test, Medical Research Council (MRC) Dyspnoea Scale and Euro Quality of Life (EQ-5D) questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>health status</measure>
    <time_frame>after 1 month</time_frame>
    <description>Health status, measured by:
the COPD Assessment Test, MRC Dyspnoea Scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>health status</measure>
    <time_frame>after 3 months</time_frame>
    <description>Health status, measured by:
the COPD Assessment Test, MRC Dyspnoea Scale and EQ-5D questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>exacerbations</measure>
    <time_frame>after 3 months</time_frame>
    <description>Frequency of exacerbations measured over a 3 month period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emergency Room visits and hospitalizations.</measure>
    <time_frame>after 3 months</time_frame>
    <description>Frequency of Emergency Room (ER) visits and hospitalizations measured over a 3 month period.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">734</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease (COPD)</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual pharmacist care in patients with Chronic Obstructive Pulmonary Disease (COPD).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pharmaceutical care intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A pharmaceutical care intervention, focused at improving inhalation technique and drug adherence in patients with Chronic Obstructive Pulmonary Disease (COPD).</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>control</intervention_name>
    <description>usual pharmacist care</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>pharmaceutical care intervention</intervention_name>
    <description>Pharmaceutical care intervention, focused at improving inhalation technique and drug adherence in patients with Chronic Obstructive Pulmonary Disease (COPD).</description>
    <arm_group_label>pharmaceutical care intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  daily use of Chronic Obstructive Pulmonary Disease (COPD)-medication: (Global
             initiative for chronic Obstructive Lung Disease: GOLD stadia I-IV)

          -  50 years of age or older

          -  smoking history of at least 10 pack-years

        Exclusion Criteria:

          -  having asthma

          -  analphabetism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guy Brusselle, M.D. , Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Ghent</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ghent University</name>
      <address>
        <city>Ghent</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire du Sart Tilman</name>
      <address>
        <city>Liege</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <link>
    <url>http://www.uzgent.be</url>
  </link>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2010</study_first_submitted>
  <study_first_submitted_qc>December 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 15, 2010</study_first_posted>
  <last_update_submitted>May 11, 2012</last_update_submitted>
  <last_update_submitted_qc>May 11, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 14, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic Obstructive Pulmonary Disease</keyword>
  <keyword>COPD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

